CSIMarket


Cannapharmarx Inc   (CPMD)
Other Ticker:  
 


 

Cannapharmarx Inc

CPMD's Financial Statements and Analysis



Cannapharmarx Inc reported break-even for the third quarter of 2023 compare to earnings per share of $0.00 recorded in the same quarter a year ago an improvement compare to $0.00 realized in previous quarter.


third quarter of 2023
Earnings Per Share Revenues
$ 0 $  0 Mill
Unch.     Unch.    



Cannapharmarx Inc 's Revenue fell by 0 % in third quarter of 2023 (Sep 30 2023) year on year, to $0 million and declined by sequentially.


Cannapharmarx Inc is

More on CPMD's Income Statement



Cannapharmarx Inc 's in thethird quarter of 2023 recorded net loss of $-0.564 million, an improvement compare to net loss of $-1.313 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-1.880 million realized in previous quarter.

More on CPMD's Growth

Cannapharmarx Inc Inventories
In Sep 30 2023 company's net cash and cash equivalents decreased by $0 million, capital expenditures grew by -0.046188-90.95%, to $0 millions compare to same quarter a year ago

More on CPMD's Cash flow Statement


Cannapharmarx Inc does not pay out common stock dividend.

In trailing twelve-month period Cannapharmarx Inc payed $